-
1
Targeting CXCL8 signaling sensitizes HNSCC to anlotinib by reducing tumor-associated macrophage-derived CLU
Published 2025-02-01Subjects: Get full text
Article -
2
Multi-omics and machine learning-driven CD8+ T cell heterogeneity score for head and neck squamous cell carcinoma
Published 2025-03-01Subjects: Get full text
Article